Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Poletti

Showing results (51-60 of 178) with videos related to

Pageof 18
Sort By:
Frontiers in Public Health|May 26, 2022
Vaccine Hesitancy, Anti-Vax, COVID-Conspirationism: From Subcultural Convergence to Public Health and Bioethical ProblemsAndrea Raballo, Michele Poletti, Antonio Preti
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|July 3, 2019
Impaired Corollary Discharge in Psychosis and At-Risk States: Integrating Neurodevelopmental, Phenomenological, and Clinical PerspectivesMichele Poletti, Alfonso Tortorella, Andrea Raballo
Neuroscience and Biobehavioral Reviews|July 24, 2012
Cognitive and affective Theory of Mind in neurodegenerative diseases: neuropsychological, neuroanatomical and neurochemical levelsMichele Poletti, Ivan Enrici, Mauro Adenzato
CNS Spectrums|May 24, 2021
Along the fringes of Agency: neurodevelopmental account of the obsessive mindMichele Poletti, Eva Gebhardt, Andrea Raballo
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 22, 2025
Lack of transparency on baseline pharmacological treatments in Clinical High-Risk for psychosis (CHR-P) may degrade precision: A systematic review and meta-analysisAndrea Raballo, Michele Poletti, Antonio Preti
JAMA Psychiatry|March 20, 2024
Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk: A Systematic Review and Meta-AnalysisAndrea Raballo, Michele Poletti, Antonio Preti
Schizophrenia Research|March 26, 2026
Duration of Active Attenuated Psychosis (DAAP): Extending time-based illness modelling to the clinical high-risk stateMichele Poletti, Antonio Preti, Andrea Raballo
Journal of Clinical and Experimental Neuropsychology|December 9, 2010
Iowa gambling task in Parkinson's diseaseMichele Poletti, Paolo Cavedini, Ubaldo Bonuccelli
The International Journal of Neuropsychopharmacology|May 26, 2021
Negative Prognostic Effect of Baseline Antipsychotic Exposure in Clinical High Risk for Psychosis (CHR-P): Is Pre-Test Risk Enrichment the Hidden Culprit?Andrea Raballo, Michele Poletti, Antonio Preti
The Journal of Neuropsychiatry and Clinical Neurosciences|May 14, 2010
Out-of-control sexual behavior in an orbitofrontal cortex-damaged elderly patientMichele Poletti, Claudio Lucetti, Ubaldo Bonuccelli
Pageof 18

Showing results (51-60 of 178) with videos related to

Sort By:
Pageof 18
Frontiers in Public Health|May 26, 2022
Vaccine Hesitancy, Anti-Vax, COVID-Conspirationism: From Subcultural Convergence to Public Health and Bioethical ProblemsAndrea Raballo, Michele Poletti, Antonio Preti
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|July 3, 2019
Impaired Corollary Discharge in Psychosis and At-Risk States: Integrating Neurodevelopmental, Phenomenological, and Clinical PerspectivesMichele Poletti, Alfonso Tortorella, Andrea Raballo
Neuroscience and Biobehavioral Reviews|July 24, 2012
Cognitive and affective Theory of Mind in neurodegenerative diseases: neuropsychological, neuroanatomical and neurochemical levelsMichele Poletti, Ivan Enrici, Mauro Adenzato
CNS Spectrums|May 24, 2021
Along the fringes of Agency: neurodevelopmental account of the obsessive mindMichele Poletti, Eva Gebhardt, Andrea Raballo
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 22, 2025
Lack of transparency on baseline pharmacological treatments in Clinical High-Risk for psychosis (CHR-P) may degrade precision: A systematic review and meta-analysisAndrea Raballo, Michele Poletti, Antonio Preti
JAMA Psychiatry|March 20, 2024
Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk: A Systematic Review and Meta-AnalysisAndrea Raballo, Michele Poletti, Antonio Preti
Schizophrenia Research|March 26, 2026
Duration of Active Attenuated Psychosis (DAAP): Extending time-based illness modelling to the clinical high-risk stateMichele Poletti, Antonio Preti, Andrea Raballo
Journal of Clinical and Experimental Neuropsychology|December 9, 2010
Iowa gambling task in Parkinson's diseaseMichele Poletti, Paolo Cavedini, Ubaldo Bonuccelli
The International Journal of Neuropsychopharmacology|May 26, 2021
Negative Prognostic Effect of Baseline Antipsychotic Exposure in Clinical High Risk for Psychosis (CHR-P): Is Pre-Test Risk Enrichment the Hidden Culprit?Andrea Raballo, Michele Poletti, Antonio Preti
The Journal of Neuropsychiatry and Clinical Neurosciences|May 14, 2010
Out-of-control sexual behavior in an orbitofrontal cortex-damaged elderly patientMichele Poletti, Claudio Lucetti, Ubaldo Bonuccelli
Pageof 18